文献速递甲状腺疾病

甲状腺微小癌诊断与治疗的相关因素分析

Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该研究基于2014或2015年确诊的分化型甲状腺癌患者调查数据,比较≤1 cm与>1 cm肿瘤的诊断路径差异。结果显示微小癌更常通过甲状腺超声发现,且更少因已知癌症而手术。理解诊断路径有助于减少过度诊断和过度治疗。

要点

  • 甲状腺微小癌更常通过超声发现结节。
  • 微小癌较少因已知癌症而安排手术。
  • 老年和女性与微小癌风险正相关。

核心结论

  • 甲状腺微小癌更可能通过超声检测发现,且较少与因已知甲状腺癌而安排的手术相关。
  • 理解诊断路径可为减少过度诊断和过度治疗提供靶向干预依据。

研究设计与样本

  • 来自乔治亚州和洛杉矶SEER登记处的2014或2015年确诊分化型甲状腺癌患者接受调查。
  • 调查数据与SEER肿瘤及治疗特征数据链接,并进行多变量逻辑回归分析。

主要发现

  • 接受手术患者中,975例(38.2%)癌症≤1 cm,1588例(61.8%)癌症>1 cm。
  • ≤1 cm与>1 cm癌症的结节发现方法差异显著(P < 0.001)。
  • 癌症≤1 cm与甲状腺超声发现结节相关(相比其他影像,OR 1.59;95% CI 1.21-2.10)。
  • 癌症≤1 cm与年龄较大(45-54岁 vs ≤44岁,OR 1.45;95% CI 1.16-1.82)和女性(OR 1.51;95% CI 1.22-1.87)正相关。
  • 西班牙裔(OR 0.71;95% CI 0.57-0.89)和亚洲种族(OR 0.67;95% CI 0.49-0.92)为负相关因素。

临床怎么用

  • 临床应关注超声发现结节在甲状腺微小癌诊断中的作用。
  • 对已知甲状腺癌安排手术时需考虑微小癌可能性较低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Nearly one-third of all thyroid cancers are ≤1 cm. OBJECTIVE: To determine diagnostic pathways for microcarcinomas vs larger cancers. DESIGN/SETTING/PARTICIPANTS: Patients from Georgia and Los Angeles Surveillance, Epidemiology, and End Results (SEER) registries with differentiated thyroid cancer diagnosed in 2014 or 2015 were surveyed. Survey data were linked to SEER data on tumor and treatment characteristics. Multivariable logistic regression analysis was performed. MAIN OUTCOME MEASURES: Method of nodule discovery; reason for thyroid surgery. RESULTS: Of patients who underwent surgery, 975 (38.2%) had cancers ≤1 cm, and 1588 cancers (61.8%) were >1 cm. The reported method of nodule discovery differed significantly between patients with cancers ≤1 cm and those with cancers >1 cm (P < 0.001). Cancer ≤1 cm was associated with nodule discovery on thyroid ultrasound (compared with other imaging, OR, 1.59; 95% CI, 1.21 to 2.10), older patient age (45 to 54 years vs ≤44, OR, 1.45; 95% CI, 1.16 to 1.82), and female sex (OR, 1.51; 95% CI, 1.22 to 1.87). Hispanic ethnicity (OR, 0.71; 95% CI, 0.57 to 0.89) and Asian race (OR, 0.67; 95% CI, 0.49 to 0.92) were negative correlates. Cancers ≤1 cm were associated with lower likelihood of surgery for a nodule suspicious or consistent with cancer (OR, 0.48; 95% CI, 0.40 to 0.57). CONCLUSION: Thyroid microcarcinomas are more likely to be detected by ultrasound and less likely to be associated with surgery scheduled for known thyroid cancer. Understanding diagnostic pathways allows for targeted interventions to decrease overdiagnosis and overtreatment.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Esfandiari NH, Hughes DT, Reyes-Gastelum D, et al. Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas. J Clin Endocrinol Metab. 2019. PMID: 31415089. doi:10.1210/jc.2019-01219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。